動物用皮膚科治療藥市場:藥物的各類型，動物的各類型，各地區-規模，佔有率，展望，機會分析，2023～2030年

獸醫皮膚病藥物是用於治療動物皮膚病的藥物。這些藥物配製用於治療皮膚癌、細菌感染和寄生蟲感染。加強獸醫醫療服務的出現使獸醫能夠為各種慢性和傳染病提供廣泛的治療選擇。這些技術使獸醫醫療服務對獸醫和寵物主人來說都更加方便和具有成本效益。

由於寵物主人對動物健康的認識不斷提高，預計未來獸用皮膚病藥物市場將出現顯著成長。此外，寄生蟲棲息地的生態變化，氣候變化，媒介與宿主相互作用增加，外來物種在流行區的導入以及傳統流行區以外媒介傳播感染的高風險也有望推動全球獸醫皮膚病學的發展。藥品市場成長。此外，更好的分子診斷和治療技術的進步有望進一步推動獸醫皮膚病藥物市場的成長。

相反，嚴格的審批規定和與藥物相關的副作用預計會限制市場成長。

目錄

第1章 調查目的與前提條件

• 調查目的
• 前提條件
• 簡稱

第2章 市場展望

• 報告概要
  • 市場定義和範圍
• 摘要整理
  • 市場概述:藥物的各類型
  • 市場概述:各動物類型
  • 市場概述:各地區
• Coherent Opportunity Map(COM)

第3章 市場動態，法律規章，趨勢分析

• 市場動態
  • 促進因素
• 動物的皮膚疾病增加
• 寵物飼主數增加
  • 阻礙因素
• 新興各國的認知度低
• 醫藥品相關的副作用
• 嚴格的核准法規
  • 商機
• 政府及民營企業投資增加
• 最尖端的治療方法的開發
• 影響度分析
• 主要的焦點
• 法規情境
• 產品銷售/核准
• PEST分析
• PORTER的分析
• 合併、收購情境

第4章 動物用皮膚科治療藥的全球市場- 冠狀病毒(COVID-19)的大流行的影響

• COVID-19流行病學調查
• 供給側和需求側的分析
• 經濟影響

第5章 動物用皮膚科治療藥的全球市場，藥物的各類型，2017年～2030年

• 抗菌藥
• 抗真菌藥物
• 抗發炎藥
• 免疫療法藥
• 寄生蟲驅除劑
• 其他

第6章 動物用皮膚科治療藥的按全球市場，動物物種，2017年～2030年

• 狗
• 貓
• 馬
• 其他

第7章 動物用皮膚科治療藥的全球市場，各地區，2017年～2030年

• 北美
• 歐洲
• 亞太地區
• 南美
• 中東、非洲地區

第8章 競爭情形

• Zoetis Inc.
• Elanco Animal Health Incorporated
• Boehringer Ingelheim International GmbH
• Virbac
• Vetoquinol S.A.
• Dechra Pharmaceuticals PLC
• Bayer AG
• Ceva Sante Animale
• Kindred Biosciences, Inc.
• IDEXX Laboratories, Inc.

第9章 Section

• 關於調查手法
• 關於出版社

Veterinary dermatology drugs are therapeutics used for the treatment of skin diseases in animals. These drugs are formulated to treat skin cancer, bacterial infections, and parasitic infestations. The emergence of enhanced veterinary medical services has enabled veterinarians to offer a wide range of treatment options for various chronic and infectious diseases. These technologies have made veterinary medical services more convenient and cost-effective for both veterinarians and pet owners.

Market Dynamics:

The veterinary dermatology drugs market is expected to witness significant growth in the future due to the rising awareness about animal health among pet owners. Additionally, changes in the ecology of parasite habitat, climate change, increase in vector-host interactions, the introduction of foreign species in endemic areas, and high risk of vector-borne infection outside traditional endemic areas are also expected to drive the global veterinary dermatology drugs market growth. Moreover, advancements in technology for better molecular diagnostics and treatments are further anticipated to propel veterinary dermatology drug market growth.

On the contrary, strict approval regulations and side effects associated with the drugs are expected to restrict market growth.

Key features of the study:

• This report provides in-depth analysis of the global veterinary dermatology drugs market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global veterinary dermatology drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Zoetis Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals PLC, Bayer AG, Ceva Sante Animale, Kindred Biosciences, Inc., and IDEXX Laboratories, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global veterinary dermatology drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary dermatology drugs market

Detailed Segmentation:

• Global Veterinary Dermatology Drugs Market, By Type of Drug:
  • Antibiotics
  • Antifungal drugs
  • Anti-inflammatory drugs
  • Immunotherapy drugs
  • Parasiticides
  • Others
• Global Veterinary Dermatology Drugs Market, By Animal Type:
  • Dogs
  • Cats
  • Horses
  • Others
• Global Veterinary Dermatology Drugs Market, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles:
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH
  • Virbac
  • Vetoquinol S.A.
  • Dechra Pharmaceuticals PLC
  • Bayer AG
  • Ceva Sante Animale
  • Kindred Biosciences, Inc.
  • IDEXX Laboratories, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type Of Drug
  • Market Snapshot, By Animal Type
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Growing prevalence of skin disease in animals
• Rise in number of pet owners
  • Restraints
• Lack of awareness across developing countries
• Side-effects associated with drugs
• Strict approval regulations
  • Opportunities
• Increasing investment by government and private sectors
• Development of cutting-edge therapies
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Veterinary Dermatology Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Veterinary Dermatology Drugs Market , By Type of Drug, 2017-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Antibiotics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• Antifungal drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• Anti-inflammatory drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• Immunotherapy drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• Parasiticides
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)

6. Global Veterinary Dermatology Drugs Market , By Animal Type, 2017-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Dogs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Billion)
• Cats
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Billion)
• Horses
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Billion)

7. Global Veterinary Dermatology Drugs Market , By Region, 2017-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Country 2017 -2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017-2030,(US$ Bn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017-2030,(US$ Bn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017-2030,(US$ Bn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017-2030,(US$ Bn)
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017-2030,(US$ Bn)

8. Competitive Landscape

• Zoetis Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Elanco Animal Health Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Boehringer Ingelheim International GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Virbac
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Vetoquinol S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Dechra Pharmaceuticals PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Ceva Sante Animale
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Kindred Biosciences, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• IDEXX Laboratories, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

9. Section

• Research Methodology
• About us